| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/21/2023 | 525% | HC Wainwright & Co. | $10 → $9 | Maintains | Buy |
| 04/17/2023 | 594.44% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 11/18/2022 | 594.44% | HC Wainwright & Co. | $36 → $10 | Maintains | Buy |
| 11/10/2022 | 872.22% | Goldman Sachs | $25 → $14 | Maintains | Buy |
| 11/09/2022 | 386.11% | Piper Sandler | $13 → $7 | Maintains | Overweight |
| 09/14/2022 | 733.33% | Berenberg | → $12 | Initiates Coverage On | → Buy |
| 05/24/2022 | 1497.22% | Goldman Sachs | $35 → $23 | Maintains | Buy |
| 05/23/2022 | 802.78% | Piper Sandler | $30 → $13 | Maintains | Overweight |
| 02/28/2022 | 1983.33% | Piper Sandler | $50 → $30 | Maintains | Overweight |
| 11/10/2021 | 2400% | HC Wainwright & Co. | $35 → $36 | Maintains | Buy |
| 06/24/2021 | 2330.56% | HC Wainwright & Co. | → $35 | Initiates Coverage On | → Buy |
| 11/03/2020 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 11/03/2020 | 3025% | Goldman Sachs | → $45 | Initiates Coverage On | → Buy |
| 11/03/2020 | 3372.22% | Piper Sandler | → $50 | Initiates Coverage On | → Overweight |
What is the target price for Kronos Bio (KRON)?
The latest price target for Kronos Bio (NASDAQ: KRON) was reported by HC Wainwright & Co. on August 21, 2023. The analyst firm set a price target for $9.00 expecting KRON to rise to within 12 months (a possible 525.00% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kronos Bio (KRON)?
The latest analyst rating for Kronos Bio (NASDAQ: KRON) was provided by HC Wainwright & Co., and Kronos Bio maintained their buy rating.
When is the next analyst rating going to be posted or updated for Kronos Bio (KRON)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kronos Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kronos Bio was filed on August 21, 2023 so you should expect the next rating to be made available sometime around August 21, 2024.
Is the Analyst Rating Kronos Bio (KRON) correct?
While ratings are subjective and will change, the latest Kronos Bio (KRON) rating was a maintained with a price target of $10.00 to $9.00. The current price Kronos Bio (KRON) is trading at is $1.44, which is out of the analyst's predicted range.